ReviewEndocrine2025
Is peptide receptor radionuclide therapy still a promising option for medullary thyroid carcinoma?
Fernanda Accioly de Andrade et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewEndocrine2025
Fernanda Accioly de Andrade et al.PubMed ↗Publisher ↗
No numbers read from the abstract.